Navigation Links
Tarantula venom-based MD therapy to be advanced by UB scientists' biotech company
Date:12/29/2009

BUFFALO, N.Y. -- University at Buffalo biophysicists have found a protein in tarantula venom that shows promise as a potential therapy for muscular dystrophy (MD). They have formed a start-up biotech company in Buffalo -- Rose Pharmaceuticals -- to advance the drug to clinical trials.

Fredrick Sachs, PhD, professor of physiology and biophysics at the University at Buffalo, and colleagues in his laboratory, discovered the peptide, called GsMTx4.

Therapies for muscular dystrophy are classed as "orphan drugs" by the FDA, allowing a shorter testing period than normal drugs. Sachs said he anticipates Rose Pharmaceuticals may be able to obtain FDA approval of the peptide for human use within two years.

The new company is named for "Rose," the pet tarantula that has been in residence in Sachs' lab for nearly 20 years.

The first target of the peptide is MD, a condition Sachs has been investigating for several years, but the peptide also has potential as a therapy for several other conditions, such as neuropathic pain and atrial fibrillation. Formation of the company was motivated by the goal of finding an MD therapy for the grandson of Sachs' friend Jeffrey Harvey.

The start-up is a collaboration between Sachs, Harvey, Thomas Suchyna, PhD, and Philip Gottlieb, PhD. Suchyna and Gottlieb, UB research scientist and UB research associate professor, respectively, have been working with Sachs at the university for several years to develop the peptide. Their work was supported by a grant from UB's Interdisciplinary Research and Creative Activities Fund.

In collaboration with Eric Hoffman, PhD, director of the Wellstone Muscular Dystrophy Center at Children's National Medical Center in Washington, D.C., the team tested the effect of GsMTx4 on MD mice extensively. Results showed that the drug increased muscle strength and caused no mortality, morbidity or toxicity.

Rose Pharmaceuticals now is concentrating on developing methods to a
'/>"/>

Contact: Lois Baker
ljbaker@buffalo.edu
716-645-4606
University at Buffalo
Source:Eurekalert

Page: 1 2

Related biology news :

1. Successful stem cell therapy for treatment of eye disease
2. Gene therapy and stem cells save limb
3. New therapy targets for amyloid disease
4. New understanding about mechanism for cell death after stroke leads to possible therapy
5. Duke develops nano-scale drug delivery for chemotherapy
6. Caltech researchers show efficacy of gene therapy in mouse models of Huntingtons disease
7. USU scientists report major advance in human antibody therapy against deadly Nipah virus
8. Patients in Europe benefit from new radiation therapy
9. LX211 highlighted as potential disease modifying therapy for non-infectious uveitis
10. Research needed to learn which DCIS patients may be candidates for less invasive therapy
11. IRSF announces funding of first clinical trial with disease-modifying therapy for Rett syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2015)... According to a new ... Area), Technology, Material (Optical Prism, Piezoelectric, Capacitive & ... Others) & Geography - Global Forecast to 2014 ... is expected to reach $14,500.07 Million by 2020, ... Browse 76 market Tables and 109 Figures spread ...
(Date:6/24/2015)... , June 24, 2015  Synaptics Inc. ... human interface solutions, today announced that Sharp has ... provide secure authentication for its latest flagship smartphone ... more than 200 million shipments of its fingerprint ... reinforces Synaptics, strength, scalability and leadership in the ...
(Date:6/23/2015)...   Valencell, a leader in performance ... recent study that illustrates its PerformTek biometric technology ... In a study conducted at Valencell,s Biometric Lab, ... Apple Watch against a chest strap – the ... The study demonstrated that Valencell,s biometric technology delivers ...
Breaking Biology News(10 mins):Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... is an inherited eye disorder characterized by progressive loss ... blindness at the end stage. , In a ChIP-Seq ... of the transcription factor Crx (Cone-rod homeobox) in the ... genetic basis for visual perception. In-depth analysis of Crx ...
... ATLANTA, Ga. Nov. 18, 2010 The 2010 Golf ... to benefit research aimed at finding better treatments and eventually ... 124 players Oct. 15, 2010, to the Crabapple Golf Club ... support the Translational Genomics Research Institute (TGen), a non-profit biomedical ...
... mysterious link between bones of an ancient lizard found in ... the Komodo dragon, half a world away in Indonesia. ... shape of the vertebrae links the 33-million-year-old African lizard fossil ... for some 700,000 years. , "The African fossil was ...
Cached Biology News:Transcription factor scan identifies genetic cause for inherited blindness 2Golf Atlanta charity tournament raises $105,000 for TGen research 2Researchers link an African lizard fossil in Africa with the Komodo dragon in Indonesia 2
(Date:6/26/2015)... , June 26, 2015  A San Francisco ... products made with synthetic rhino horn: beer in ... Vietnam . In response to the emerging ... manufacture, marketing and sale of synthetic rhino horn.  ... and Save the Rhino International (SRI) released ...
(Date:6/26/2015)... ... June 26, 2015 , ... Claremont BioSolutions, LLC, a ... been integrated into a sample prep module intended to enable real-time quantitative gene ... the NASA’s WetLab-2 Project. , On June 28, 2015, SpaceX CRS-7 will launch ...
(Date:6/26/2015)... , ... June 26, 2015 , ... ... services and a subsidiary of OraSure Technologies, Inc. (Nasdaq: OSUR) today announced that ... as part of its Gut Microbiome Grant Program. The company has awarded its ...
(Date:6/26/2015)... (PRWEB) , ... June 26, 2015 , ... ReliantHeart, ... that indicates that from the first implant of the HeartAssist5® LVAD (HA5) to the ... the HA5. , Thrombus that originates in an LVAD is referred to as ...
Breaking Biology Technology:Rhino Experts Oppose Synthetic Rhino Horn as Solution to Poaching Crisis 2Claremont BioSolutions’ SimplePrep™ Products Deployed in NASA Wetlab-2 Project Slated for June 28th Flight to International Space Station aboard SpaceX CRS-7 2Claremont BioSolutions’ SimplePrep™ Products Deployed in NASA Wetlab-2 Project Slated for June 28th Flight to International Space Station aboard SpaceX CRS-7 3DNA Genotek Inc. Announces Recipients of Gut Microbiome Grant Program 2DNA Genotek Inc. Announces Recipients of Gut Microbiome Grant Program 3HeartAssist5® Remote Monitoring has alerted no patterns of de novo thrombus in 68 consecutive implants 2HeartAssist5® Remote Monitoring has alerted no patterns of de novo thrombus in 68 consecutive implants 3
... Those who attended the BIO2003 Conference in Washington D.C. ... experience. First, it was attended by over 16,000 people ... filled with dignitaries such as President Bush, Secretary Tommy ... though, the conference showcased the efforts of research scientist ...
... freeze budget proposal? Legislative Republicans voted for it because they ... convinced the freeze was good policy and secretly hoped Doyle ... Democrats and Gov. Jim Doyles proposal to raise the state ... vote for such a populist bill if it reaches the ...
... Reviving the Economy , ,* * * * * * ... from last week's DEMOmobile 2003, and the experience has only strengthened ... the overall economy. The energy from the 400-plus attendees and 37 ... crystal clear: True connectivity -- both in our homes and our ...
Cached Biology Technology:Let's Get Serious 2Doyle and the Legislature Have Much To Agree Upon When It Comes To The Economy 2Doyle and the Legislature Have Much To Agree Upon When It Comes To The Economy 3The News From DEMOmobile 2003 2The News From DEMOmobile 2003 3
... PTOs are internucleotide modifications, where one ... replaced by a sulphur atom. This modification ... are available as Full-PTOs ... with thio-caps Several internucleotide ...
... The VARIOKLAV 75 S and 135 S steam ... double bottoms combine the advantages of a double-walled ... use, effective deaeration and drying by built-in jacket ... - fast cooling. The chamber is free of ...
Request Info...
... catalyzes the transfer of the gamma-phosphate ... single- and double-stranded DNA, RNA, and ... the 3'-phosphate from 3'-phosphoryl polynucleotides, deoxyribonucleoside ... form a 3'-hydroxyl group. Storage Buffer: ...
Biology Products: